Branched-chain Amino Acids Supplementation and Resistance Exercise-induced Muscle Damage and Inflammation
NCT ID: NCT01305018
Last Updated: 2011-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
30 participants
INTERVENTIONAL
2011-08-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Branched-chain Amino Acids, and Resistance Exercise on Skeletal Muscle Signaling Pathways
NCT01350427
Effect of Branched-chain Amino Acid Supplementation on Muscle Damage
NCT03766815
Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids
NCT01529281
Branched Chain Amino Acid Plus Glucose Supplement Reduces Exercise-Induced Delayed Onset Muscle Soreness in College Females
NCT01781910
Effect of Amino Acid on Muscle Damage
NCT03319147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise and BCAA
BCAA
7 g of leucine + 3,5 g of isoleucine + 3,5 g of valine per day during 9 days
Exercise and Leucine
Leucine
7 g of leucine + 7 g of alanine per day during 9 days
Exercise and Placebo
Placebo
14 g of alanine per day during 9 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BCAA
7 g of leucine + 3,5 g of isoleucine + 3,5 g of valine per day during 9 days
Leucine
7 g of leucine + 7 g of alanine per day during 9 days
Placebo
14 g of alanine per day during 9 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No muscle disorders;
* Must be able to swallow tablets
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of São Paulo - School of Physical Education and Sports
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
071287
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.